Nigeria

v. 27 – Q3 2023

Market Executive Summary In 2014, requirements to apply security labels allowing verification of serial numbers applicable for antimalarials and antibiotics were put in place. Otherwise, inactive market for Serialisation.

May 2020: Publication of the “Nigeria National Pharmaceutical Traceability Strategy” aiming for additional serialisation and traceability requirements and a 5-year roadmap.

October 2022: Draft legislation published for consultation, aligned to National Traceability Strategy (Draft legislation published for discussion : Sets out strategic direction (traceability of medicines, commitment to GS1 standards), also master data guidance.

Ambition states that “it is expected that traceability becomes fully operational in the Nigerian Pharmaceutical Supply Chain by the end of the year 2024” but no firm requirements yet for medicines.

Key Dates
  • December 2022: Consultation closed and under review; no feedback yet
  • August 2022: Draft legislation published and open for public consultation review until October 2022
  • May 2020: Publication of the “Nigeria National Pharmaceutical Traceability Strategy” aiming for additional serialisation and traceability requirements and a 5-year roadmap. Proposed high-level milestones
    • Coding guidance within 6 to 12 months
    • Outline of traceability requirements within 12 to 18 months
    • Leading to implementation within 5 years
  • 2014: Security labels on antimalarials and antibiotics

<-- Return to Countries